112 related articles for article (PubMed ID: 9210037)
1. A novel assay for hepatitis B e markers.
Boxall EH; Peterson S; Diment J; Graham SE; Shirley JA
J Med Virol; 1997 Jul; 52(3):280-5. PubMed ID: 9210037
[TBL] [Abstract][Full Text] [Related]
2. Performance evaluation of the ADVIA Centaur anti-HBe and HBeAg assays.
van Helden J; Cornely C; Dati F; Levy HR; Bal T; Seeger M; Wright T; Baker L
J Clin Virol; 2008 Oct; 43(2):169-75. PubMed ID: 18635392
[TBL] [Abstract][Full Text] [Related]
3. [Titers of selected indicators of hepatitis B in the blood of patients with acute viral hepatitis].
Rzeszowska G; Mazurek E; Mierzejewska I; Fijałka-Rymar M; Ignaciuk A
Ann Univ Mariae Curie Sklodowska Med; 1987; 42():89-94. PubMed ID: 3154901
[No Abstract] [Full Text] [Related]
4. [Viral marker related to antigen and antibody of hepatitis B virus].
Arase Y
Nihon Rinsho; 2010 Jun; 68 Suppl 6():439-42. PubMed ID: 20942098
[No Abstract] [Full Text] [Related]
5. [Mechanisms of hepatitis B e antigen seroconversion from the aspect of viral mutation].
Torii N; Hasegawa K; Oomori K; Shiratori K
Nihon Rinsho; 2004 Aug; 62 Suppl 8():93-7. PubMed ID: 15453294
[No Abstract] [Full Text] [Related]
6. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.
van Helden J; Denoyel G; Karwowska S; Reamer R; Schmalz J; Wright T; Preisel-Simmons B
Clin Lab; 2004; 50(1-2):63-73. PubMed ID: 15000222
[TBL] [Abstract][Full Text] [Related]
7. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
Han Y; Tang Q; Zhu W; Zhang X; You L
J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
[TBL] [Abstract][Full Text] [Related]
8. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels.
Chu CM; Hung SJ; Lin J; Tai DI; Liaw YF
Am J Med; 2004 Jun; 116(12):829-34. PubMed ID: 15178498
[TBL] [Abstract][Full Text] [Related]
9. European performance evaluations of the ADVIA Centaur infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics.
Dati F; Denoyel G; van Helden J
J Clin Virol; 2004 Apr; 30 Suppl 1():S6-10. PubMed ID: 15062761
[TBL] [Abstract][Full Text] [Related]
10. [Interferon treatment in chronic hepatitis B].
Pastore G; Santantonio T; Milella M; Iacovazzi T; Longo A; Pietromatera G
Minerva Gastroenterol Dietol; 1995 Mar; 41(1):97-102. PubMed ID: 7619970
[No Abstract] [Full Text] [Related]
11. Hepatitis B virus e antigen specific epitopes and limitations of commercial anti-HBe immunoassays.
Baumeister MA; Medina-Selby A; Coit D; Nguyen S; George-Nascimento C; Gyenes A; Valenzuela P; Kuo G; Chien DY
J Med Virol; 2000 Mar; 60(3):256-63. PubMed ID: 10630956
[TBL] [Abstract][Full Text] [Related]
12. Transmission of a homogenous hepatitis B virus population of A1896-containing strains leading to mild resolving acute hepatitis and seroconversion to hepatitis B e antigen antibodies in an adult.
Mphahlele MJ; Shattock AG; Boner W; Quinn J; McCormick PA; Carman WF
Hepatology; 1997 Sep; 26(3):743-6. PubMed ID: 9303507
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
Challine D; Chevaliez S; Pawlotsky JM
Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749
[TBL] [Abstract][Full Text] [Related]
14. Assessment of hepatitis B "e" antigen and "e" antibody status--tests of status or status of tests?
Westmoreland D; Parr A; Thomas AJ
J Med Microbiol; 1994 Dec; 41(6):374-7. PubMed ID: 7966211
[TBL] [Abstract][Full Text] [Related]
15. A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter.
Yamaura T; Tanaka E; Matsumoto A; Rokuhara A; Orii K; Yoshizawa K; Miyakawa Y; Kiyosawa K
J Med Virol; 2003 Aug; 70(4):545-52. PubMed ID: 12794716
[TBL] [Abstract][Full Text] [Related]
16. [Clinical course and outcome of acute hepatitis B in relation to the markers of the E system].
Iushchuk ND; Shestakova IV; Klimova EA; Sergeeva NA; Malyshev NA; Braginskiĭ DM; Favorov MO
Ross Med Zh; 1992; (4):42-4. PubMed ID: 1521021
[No Abstract] [Full Text] [Related]
17. Development of up-converting phosphor technology-based lateral-flow assay for rapidly quantitative detection of hepatitis B surface antibody.
Li L; Zhou L; Yu Y; Zhu Z; Lin C; Lu C; Yang R
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):165-72. PubMed ID: 19150709
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
Kao JH; Chen PJ; Lai MY; Chen DS
J Med Virol; 2004 Mar; 72(3):363-9. PubMed ID: 14748059
[TBL] [Abstract][Full Text] [Related]
19. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
Katz L; Strong DM; Tegtmeier G; Stramer S
Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
[TBL] [Abstract][Full Text] [Related]
20. Viral quasi-species evolution during hepatitis Be antigen seroconversion.
Lim SG; Cheng Y; Guindon S; Seet BL; Lee LY; Hu P; Wasser S; Peter FJ; Tan T; Goode M; Rodrigo AG
Gastroenterology; 2007 Sep; 133(3):951-8. PubMed ID: 17854598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
